Clinical utility of DaTscan™ (123I-Ioflupane Injection) in the diagnosis of Parkinsonian Syndromes

References

• TolosaEWenningEPoeweWThe diagnosis of Parkinson’s diseaseLancet Neurol200651758616361025
   PubMed Web of Science ®Google Scholar
• de LauLMBretelerMMEpidemiology of Parkinson’s diseaseLancet Neurol20065652553516713924
   PubMed Web of Science ®Google Scholar
• NussbaumRLEllisCEAlzheimer’s disease and Parkinson’s diseaseN Engl J Med2003348141356136412672864
   PubMed Web of Science ®Google Scholar
• MacpheeGJStewartDAParkinson’s diseaseRev Clin Gerontol200616121
   Google Scholar
• LeesAJHardyJReveszTParkinson’s diseaseLancet200937396802055206619524782
   PubMed Web of Science ®Google Scholar
• ChaudhuriKRMartinez-MartinPBrownRGThe metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot studyMov Disord200722131901191117674410
   PubMed Web of Science ®Google Scholar
• HughesAJDanielSEKilfordLLeesAJAccuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinic-pathological study of 100 casesJ Neurol Neurosurg Psychiatry19925531811841564476
   PubMed Web of Science ®Google Scholar
• HughesAJDanielSEBen-ShlomoYLeesAJThe accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder serviceBrain2002125Pt486187011912118
   PubMed Web of Science ®Google Scholar
• ReijndersJSEhrtUWeberWEAarslandDLeentjensAFA systematic review of prevalence studies of depression in Parkinson’s diseaseMov Disord200823218318917987654
   PubMed Web of Science ®Google Scholar
• FahnSEltonRLfor UPDRS program membersUnified Parkinson’s disease rating scaleFahnSMarsdenCDGoldsteinMCalneDBRecent Developments in Parkinson’s DiseaseFlorham ParkMacmillan Healthcare Information19872153163293304
   Google Scholar
• HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
   PubMed Web of Science ®Google Scholar
• BrownRGDittnerAFindleyLWesselySCThe Parkinson fatigue scaleParkinsonism Relat Disord2005111495515619463
   PubMed Web of Science ®Google Scholar
• EvansJRMasonSLWilliams-GrayCHThe natural history of treated Parkinson’s disease in an incident, community based cohortJ Neurol Neurosurg Psychiatry201182101112111821593513
   PubMed Web of Science ®Google Scholar
• FolsteinMFFolsteinSEMcHughPR“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res19751231891981202204
   PubMed Web of Science ®Google Scholar
• NasreddineZSPhillipsNABédirianVThe Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairmentJ Am Geriatr Soc200553469569915817019
   PubMed Web of Science ®Google Scholar
• LessigSNieDXuRCorey-BloomJChanges on brief cognitive instruments over time in Parkinson’s diseaseMov Disord20122791125112822692724
   PubMed Web of Science ®Google Scholar
• DotyRLDeemsDAStellarSOlfactory dysfunction in Parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease durationNeurology1988388123712443399075
   PubMed Web of Science ®Google Scholar
• DotyRLOlfactory dysfunction in Parkinson diseaseNat Rev Neurol20128632933922584158
   PubMed Web of Science ®Google Scholar
• DotyRLShamanPDannMDevelopment of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory functionPhysiol Behav19843234895026463130
   PubMed Web of Science ®Google Scholar
• HummelTSekingerBWolfSRPauliEKobalG‘Sniffin’ sticks’: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory thresholdChem Senses199722139529056084
   PubMed Web of Science ®Google Scholar
• MüllerAMüngersdorfMReichmannHStrehleGHummelTOlfactory function in Parkinsonian syndromesJ Clin Neurosci20029552152412383407
   PubMed Web of Science ®Google Scholar
• LouterMAardenWCLionJBloemBROvereemSRecognition and diagnosis of sleep disorders in Parkinson’s diseaseJ Neurol2012259102031204022535255
   PubMed Web of Science ®Google Scholar
• ChaudhuriKRPalSDiMarcoAThe Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s diseaseJ Neurol Neurosurg Psychiatry200273662963512438461
   PubMed Web of Science ®Google Scholar
• BuysseDJReynoldsCF3rdMonkTHBermanSRKupferDJThe Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchPsychiatry Res19892821932132748771
   PubMed Web of Science ®Google Scholar
• HardyJCaiHCooksonMRGwinn-HardyKSingletonAGenetics of Parkinson’s disease and ParkinsonismAnn Neurol200660438939817068789
   PubMed Web of Science ®Google Scholar
• TanEKJankovicJGenetic testing in Parkinson disease: promises and pitfallsArch Neurol20066391232123716966499
   PubMedGoogle Scholar
• PolymeropoulosMHLavedanCLeroyEMutation in the alpha-synuclein gene identified in families with Parkinson’s diseaseScience19972765321204520479197268
   PubMed Web of Science ®Google Scholar
• Paisán-RuízCJainSEvansEWCloning of the gene containing mutations that cause PARK8-linked Parkinson’s diseaseNeuron200444459560015541308
   PubMed Web of Science ®Google Scholar
• ZimprichAMüller-MyhsokBFarrerMThe PARK8 locus in autosomal dominant Parkinsonism: confirmation of linkage and further delineation of the disease-containing intervalAm J Hum Genet2004741111914691730
   PubMed Web of Science ®Google Scholar
• KitadaTAsakawaSHattoriNMutations in the parkin gene cause autosomal recessive juvenile ParkinsonismNature199839266766056089560156
   PubMed Web of Science ®Google Scholar
• BonifatiVRizzuPvan BarenMJMutations in the DJ-1 gene associated with autosomal recessive early-onset ParkinsonismScience2003299560425625912446870
   PubMed Web of Science ®Google Scholar
• ValenteEMAbou-SleimanPMCaputoVHereditary early-onset Parkinson’s disease caused by mutations in PINK1Science200430456741158116015087508
   PubMed Web of Science ®Google Scholar
• NeumeyerJLWangSGaoYN-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transportersJ Med Chem19943711155815618201589
   PubMed Web of Science ®Google Scholar
• European Medicines AgencySummary of Product CharacteristicsLondonEuropean Medical Agency2011 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000266/WC500035355.pdfAccessed November 9, 2012
   Google Scholar
• LeungKN-(3-Fluoropropyl)-2β-carbomethoxy-3β-(4-[123I] iodophenyl) nortropaneMolecular Imaging and Contrast Agent Database (MICAD) [Internet]BethesdaNational Center for Biotechnology Information20042013
   Google Scholar
• BooijJAndringaGRijksLJ[123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeysSynapse19972731831909329154
   PubMed Web of Science ®Google Scholar
• GirosBCaronMGMolecular characterization of the dopamine transporterTrends Pharmacol Sci199314243498480373
   PubMed Web of Science ®Google Scholar
• BooijJBusemann SokoleEStabinMGJanssenAGde BruinKvan RoyenEAHuman biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transportersEur J Nucl Med199825124309396871
   PubMedGoogle Scholar
• LundkvistCHalldinCSwahnCG[O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinationsNucl Med Biol19952279059138547888
   PubMed Web of Science ®Google Scholar
• GüntherIHallHHalldinCSwahnCGFardeLSedvallG[125I] beta-CIT-FE and [125I] beta-CIT-FP are superior to [125I] beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brainNucl Med Biol19972476296349352533
   PubMed Web of Science ®Google Scholar
• BooijJde JongJde BruinKKnolRde WinMMvan Eck-SmitBLQuantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjectsJ Nucl Med200748335936617332612
   PubMed Web of Science ®Google Scholar
• LavalayeJKnolRJde BruinKRenemanLJanssenAGBooijJ[123I] FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medicationEur J Nucl Med200027334634910774889
   PubMedGoogle Scholar
• Food and Drug AdministrationCenter for Drug Evaluation and ResearchSilver Spring, Maryland, USAFood and Drug Administration2011 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/022454sOrig1s000Lbl.pdfAccessed November 9, 2012
   Google Scholar
• ScherflerCNockerMDopamine transporter SPECT: how to remove subjectivity?Mov Disord200924Suppl 2S721S72419877234
   PubMed Web of Science ®Google Scholar
• BenamerHTOertelWHPattersonJProspective study of presynaptic dopaminergic imaging in patients with mild Parkinsonism and tremor disorders: part 1. Baseline and 3-month observationsMov Disord200318997798414502664
   PubMed Web of Science ®Google Scholar
• Benito-LeónJLouisEDBermejo-ParejaFNeurological Disorders in Central Spain Study GroupRisk of incident Parkinson’s disease and Parkinsonism in essential tremor: a population based studyJ Neurol Neurosurg Psychiatry200980442342519289477
   PubMed Web of Science ®Google Scholar
• BenamerTSPattersonJGrossetDGAccurate differentiation of Parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study groupMov Disord2000153503510
   PubMed Web of Science ®Google Scholar
• MarshallVLReiningerCBMarquardtMParkinson’s disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECTMov Disord200924450050819117369
   PubMed Web of Science ®Google Scholar
• de la Fuente-FernándezRRole of DaTSCAN and clinical diagnosis in Parkinson diseaseNeurology2012781069670122323748
   PubMed Web of Science ®Google Scholar
• AntoniniABentiRDe NotarisR123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsyNeurol Sci200324314915014598060
   PubMed Web of Science ®Google Scholar
• PlotkinMAmthauerHKlaffkeSCombined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patientsJ Neural Transm2005112567769215375677
   PubMed Web of Science ®Google Scholar
• CiliaRRossiCFrosiniDDopamine transporter SPECT imaging in corticobasal syndromePLoS One201165e1830121559307
   PubMed Web of Science ®Google Scholar
• VlaarAMde NijsTKesselsAGDiagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromesEur Neurol200859525826618264015
   PubMed Web of Science ®Google Scholar
• ZijlmansJCDanielSEHughesAJRévészTLeesAJClinicopathological investigation of vascular Parkinsonism, including clinical criteria for diagnosisMov Disord200419663064015197700
   PubMed Web of Science ®Google Scholar
• ContrafattoDMostileGNicolettiA[(123)I]FP-CIT-SPECT asymmetry index to differentiate Parkinson’s disease from vascular ParkinsonismActa Neurol Scand20121261121621916850
   PubMed Web of Science ®Google Scholar
• WalkerZJarosEWalkerRWDementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsyJ Neurol Neurosurg Psychiatry200778111176118117353255
   PubMed Web of Science ®Google Scholar
• TolosaECoelhoMGallardoMDAT imaging in drug-induced and psychogenic ParkinsonismMov Disord200318Suppl 7S28S33
   Web of Science ®Google Scholar
• GaigCMartíMJTolosaE123I-Ioflupane SPECT in the diagnosis of suspected psychogenic ParkinsonismMov Disord200621111994199816941463
   PubMed Web of Science ®Google Scholar
• ToweyDJBainPGNijranKSAutomatic classification of 123I-FP-CIT (DaTSCAN) SPECT imagesNucl Med Commun201132869970721659911
   PubMed Web of Science ®Google Scholar
• IllanIAGorrzJMRamirezJSegoviaFJiminez-HoyuelaJMOrtega LozanoSJAutomatic assistance to Parkinson’s disease diagnosis in DaTSCAN SPECT imagingMed Phys201239105971598023039635
   PubMed Web of Science ®Google Scholar
• SegoviaFGorrizJMRamirezJAlvarezIJimenez-HoyuelaJMOrtegaSJImproved Parkinsonism diagnosis using a partial least squares based approachMed Phys20123974395440322830772
   PubMed Web of Science ®Google Scholar
• Van LaereKEveraertLAnnemansLGonceMVandenbergheWVander BorghtTThe cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of ParkinsonismEur J Nucl Med Mol Imaging20083571367137618385998
   PubMed Web of Science ®Google Scholar
• AntoniniABertoPLopatrielloSTammaFAnnemansLChambersMCost-effectiveness of 123I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson’s disease in ItalyMov Disord200823152202220918785639
   PubMed Web of Science ®Google Scholar
• KupschARBajajNWeilandFImpact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled studyJ Neurol Neurosurg Psychiatry201283662062822492213
   PubMed Web of Science ®Google Scholar